Dexamethasone sodium phosphate and Scabene drug interactions - a phase IV clinical study of FDA data
Summary:
We study 12,101 people who take Dexamethasone sodium phosphate (dexamethasone sodium phosphate) and Scabene (lindane). There is no drug interaction reported.
The study analyzes what interactions people have when they take Dexamethasone sodium phosphate and Scabene. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Dexamethasone sodium phosphate?
Dexamethasone sodium phosphate has active ingredients of dexamethasone sodium phosphate. It is often used in multiple myeloma. eHealthMe is studying from 12,101 Dexamethasone sodium phosphate users. Check the latest studies of Dexamethasone sodium phosphate.
What is Scabene?
Scabene has active ingredients of lindane.
No report is found.
Do you take Dexamethasone sodium phosphate and Scabene?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Dexamethasone sodium phosphate (12,101 reports)
- Scabene
How the study uses the data?
The study uses data from the FDA. It is based on dexamethasone sodium phosphate and lindane (the active ingredients of Dexamethasone sodium phosphate and Scabene, respectively), and Dexamethasone sodium phosphate and Scabene (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Orilissa cause General Symptom? - 8 seconds ago
- Could Nitro-Bid cause Cellulitis Aggravated? - 11 seconds ago
- Could Hydroxyzine Hydrochloride cause Cellulitis? - 12 seconds ago
- Could Opsumit cause Intracardiac Thrombus? - 12 seconds ago
- Fluoxetine and Thoughts - Cloudy for Women aged 60+ - 14 seconds ago
- Fluoxetine and Thinking - Unclear for Women aged 60+ - 14 seconds ago
- Fluoxetine and Disorientation for Women aged 60+ - 15 seconds ago
- Fluoxetine and Confusion for Women aged 60+ - 15 seconds ago
- Drug interactions of Sulfasalazine and Ms Contin - 21 seconds ago
- Hepatitis B and Peripheral Swelling - 22 seconds ago